The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer

导出原文传递

翻译打印收藏纠错

作者： Xu, Xia ^[1] ; Deng, Fei ^[2] ; Lv, Mengmeng ; Chen, Xiaoxiang

作者单位： Jiangsu Canc Hosp, Dept Gynecol Oncol, 42 Baiziting St, Nanjing 210009, Jiangsu, Peoples R China ^[1] Jiangsu Canc Hosp, Dept Chemotherapy, 42 Baiziting St, Nanjing 210009, Jiangsu, Peoples R China ^[2]

关键词 High-grade serous ovarian cancer (HG-SOC)CA-125 Neoadjuvant chemotherapy (NAC)Interval debulking surgery (IDS)Clinical complete response (CCR)

发布时间 2017-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Archives of gynecology and obstetrics.

2017年295卷2期

451-458页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer

Archives of gynecology and obstetrics.

相似文献

Archives of gynecology and obstetrics.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer

Archives of gynecology and obstetrics.

相似文献

Archives of gynecology and obstetrics.

相关期刊

检索历史清除